Opioid Maker's Investors Say Co. Illegally Marketed Drug
Shareholders of pharmaceutical company Insys Therapeutics Inc. accused the company's board in a derivative suit Wednesday in Delaware Chancery Court of breaching its fiduciary duty by implementing a plan to market...To view the full article, register now.
Already a subscriber? Click here to view full article